{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:57:29Z","timestamp":1788472649815,"version":"build-2803163510"},"reference-count":10,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To demonstrate an inflammatory process in the central nervous system, the presence of at least two immunoglobulin (Ig) bands in the cerebrospinal fluid (CSF) is required. So far, the presence of a single abnormal Ig band is considered as negative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The objective was to assess retrospectively the significance of a single CSF Ig band in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results:<\/jats:title>\n                    <jats:p>Out of 10,286 CSF analyses, we retained 214 results with single Ig. An inflammatory neurological disorder was diagnosed in 41% of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Despite a modest sensitivity, the presence of a single CSF Ig band may be a biomarker of an inflammatory mechanism and, as such, may prompt the clinician to repeat the analysis when the clinical context remains suggestive.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1352458520978222","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T13:41:06Z","timestamp":1607607666000},"page":"1451-1454","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical significance of a single cerebrospinal fluid immunoglobulin band: A retrospective study"],"prefix":"10.1177","volume":"27","author":[{"given":"Maud","family":"Tusseau","sequence":"first","affiliation":[{"name":"Hospices Civils de Lyon, Laboratoire d\u2019immunologie, H\u00f4pital \u00c9douard Herriot, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Cheli","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Laboratoire d\u2019immunologie, H\u00f4pital \u00c9douard Herriot, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Marignier","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, service de neurologie, scl\u00e9rose en plaques, pathologies de la my\u00e9line et neuro-inflammation, Centre de Ressources, Recherche et Comp\u00e9tence pour la Scl\u00e9rose en Plaques (C2RC-SEP), Centre de R\u00e9f\u00e9rence pour les Maladies Inflammatoires Rares du Cerveau et de la Moelle Epini\u00e8re (MIRCEM), H\u00f4pital Neurologique Pierre Wertheimer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Poitevin","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Laboratoire d\u2019immunologie, H\u00f4pital \u00c9douard Herriot, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Malcus","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Laboratoire d\u2019immunologie, H\u00f4pital \u00c9douard Herriot, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Gossez","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Laboratoire d\u2019immunologie, H\u00f4pital \u00c9douard Herriot, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bancel","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Laboratoire d\u2019immunologie, H\u00f4pital \u00c9douard Herriot, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9961-5739","authenticated-orcid":false,"given":"Guillaume","family":"Monneret","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Laboratoire d\u2019immunologie, H\u00f4pital \u00c9douard Herriot, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7337-7122","authenticated-orcid":false,"given":"Sandra","family":"Vukusic","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, service de neurologie, scl\u00e9rose en plaques, pathologies de la my\u00e9line et neuro-inflammation, Centre de Ressources, Recherche et Comp\u00e9tence pour la Scl\u00e9rose en Plaques (C2RC-SEP), Centre de R\u00e9f\u00e9rence pour les Maladies Inflammatoires Rares du Cerveau et de la Moelle Epini\u00e8re (MIRCEM), H\u00f4pital Neurologique Pierre Wertheimer, Lyon, France\/CNRS UMR5292, Centre des Neurosciences de Lyon, Observatoire Fran\u00e7ais de la Scl\u00e9rose en Plaques, INSERM 1028, Facult\u00e9 de m\u00e9decine Lyon Est,..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"bibr1-1352458520978222","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304695"},{"key":"bibr2-1352458520978222","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.41"},{"key":"bibr3-1352458520978222","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215410"},{"key":"bibr4-1352458520978222","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"bibr5-1352458520978222","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.8.897"},{"key":"bibr6-1352458520978222","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.6.865"},{"key":"bibr7-1352458520978222","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055864.08740.CB"},{"key":"bibr8-1352458520978222","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8480-5"},{"key":"bibr9-1352458520978222","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.62.4.675"},{"key":"bibr10-1352458520978222","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1684\/abc.2016.1170","volume":"74","author":"Lef\u00e8vre C","year":"2016","journal-title":"Annales De Biologie Clinique"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458520978222","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1352458520978222","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458520978222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:05:35Z","timestamp":1777694735000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1352458520978222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1177\/1352458520978222"],"URL":"https:\/\/doi.org\/10.1177\/1352458520978222","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]}}}